Wedbush Downgrades Alpine Immune Sciences to Neutral
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Robert Driscoll downgrades Alpine Immune Sciences (NASDAQ:ALPN) from Outperform to Neutral.

April 11, 2024 | 12:18 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alpine Immune Sciences was downgraded by Wedbush analyst Robert Driscoll from Outperform to Neutral.
Analyst ratings often influence stock prices in the short term. A downgrade from 'Outperform' to 'Neutral' suggests a less optimistic outlook on the stock by the analyst, which could lead to a decrease in investor confidence and potentially lower the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100